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ABSTRACT
Wasting syndrome in acquired immunodeficiency syndrome (AIDS) appears to play a role in
decline of immune function. Along with poor appetite, HIV infected individuals seem to have a
tendency to be heavy alcohol drinkers which may be immunosuppressive and cause malnutrition.
Altered macronutrient metabolism visibly contributes to wasting; however, micronutrient
deficiencies also appear to play a role. Micronutrient deficiency has also been known to decrease
immune function. As part of their role as antioxidants, P-carotene, vitamin C, vitamin E, and
selenium may be helpful in altering cell production and response to cytokines and other secretions.
This may decrease viral replication and prevent wasting syndrome.

INTRODUCTION
In 1996, the prevalence of acquired immunodeficiency syndrome (AIDS) in the United
States was 235,470 (1). This is a 11% increase from 1995 when the number of people with AIDS
was 173,560. However, in the same time period the mortality rate decreased 23% from 50,140 to
38, 780 due to the advances made in HIV therapies. In addition to more effective medication,
diet and nutrition has also been found to play an important role in the mortality of AIDS patients.
Since weight loss, malnutrition and wasting are characteristic traits of human immunodeficiency
virus (HIV) and AIDS, it was estimated that approximately 80% of patients with HIV/AIDS died
malnourished in the recent past (2). While many patients still suffer from malnourishment and
wasting, proper nutritional intervention has been found to help in treating and restoring immune
function as well as preventing disease progression and weight loss (3). The effects of single

nutrients on the immune system and progression of AIDS have been of particular interest lately.
This paper will focus on the effects of alcohol and antioxidants in the progression of AIDS.

REVIEW OF IMMUNE RESPONSE
The body consists of two types of immune responses to antigens (foreign material in the
body): humoral and cell-mediated (4). The humoral response consists ofB-lymphocytes which
can be divided into memory and plasma cells (4). Memory B-cells remember previous antigens so
that the body can respond to the same type of antigens quicker than at the time of original
exposure. After exposure to a familiar antigen, memory B-cells transform into plasma B-cells,
which produce antibodies that interact with the antigen (4).
Cell-mediated response is the body's main defense against antigens (4). It consists of Tlymphocytes, natural killer cells, and monocytes. T-lymphocytes also have memory cells, but
effector cells to carry out the main action against the antigen (4). Helper, suppressor, and
cytotoxic lymphocytes are those that are termed as effector cells. Helper T-lymphocytes (CD4)
signal memory B-cells to transform into plasma B-cells (4). Conversely, suppressor Tlymphocytes signal B-cells to stop transformation (4). When antibodies from B-cells identify
antigens, cytotoxic T-lymphocytes (CDS) and natural killer cells are then able to destroy the cells
that are infected by the antigen (4).
Monocytes are the other type of cell-mediated response. Through conversion into
macrophages, this type of cell becomes extremely phagocytic and is able to process the antigen so
that it is recognized by T and B-lymphocytes (4). Another function of monocytes is to produce
cytokines and prostaglandins to help regulate the immune responses in the body (4). (However,
monocytes are not the only type of immune cell to produce these substances.)

HIV INFECTION PROCESS
HIV is a Ribonucleic Acid (RNA) retrovirus (3). When the virus enters a new host, it is
covered with cell membranes, antibodies, and/or complement from the infected donor (5). This
enables the host's immune system to recognize it as foreign to the body and treat it like an antigen
complex (5). Through an interaction with helper T lymphocytes (CD4+) and macrophages, the
retrovirus binds to the surface receptors of these cells and is internalized (5,6). Once inside, the
retrovirus is uncoated and the viral RNA is transcribed to Deoxyribonucleic Acid (DNA), using an
enzyme called reverse transcriptase (3,6). The proviral DNA is then incorporated into the host's
chromosomal DNA through use of a viral enzyme, endonuclease (6). This is how the host
chromosomal DNA remains for the life of the cell (6). The virus, however, continues to
transcribe RNA into DNA, thus causing an accumulation of proviral DNA to build up in the
cytoplasm (6).
Even with the proviral DNA incorporated into the cell's chromosomal DNA, the integrity
of the cell is maintained for as long as the viral DNA remains latent (6). Antigens, coinfecting
viruses, and cytokines can activate the viral DNA. When this happens, the DNA is transcribed
into massager RNA (mRNA) (6). This is then translated into viral proteins which are responsible
for virion RNA replication (6). When virion RNA is produced, the virion RNA and a viral
protein envelope then bud off from the cell to infect other cells (6).
The HIV infection targets the host's CD4+ cells and progressively depletes them (7).
Since these cells are a major part of the body's defenses against infection, HIV infection
eventually leads to immunodeficiency, secondary infections, and neoplasms (7). Other immune
cells (e.g. B-lymphocytes, monocytes, and macrophages) are also affected by HIV (6).
The amount of time varies for each individual from HIV infection to development of AIDS

(7). It usually takes around 7-11 years for the infection to progress to AIDS (8). AIDS is
diagnosed when an individual is HIV seropositive and has wasting syndrome (or another life
threatening clinical condition that can unequivocally be linked to HIV-induced
immunosuppression) (7,8). Also, an HIV-infected individual with a CD4 cell count of less than
200 cu/mm, regardless of clinical status are diagnosed as having full blown AIDS (9).

WASTING SYNDROME
Wasting syndrome is defined by the Center for Disease Control (CDC) as involuntary
weight loss of greater than or equal to 10% of original body weight in one month (7). The
etiologies of wasting syndrome is decreased food intake, malabsorption, and cachexia (10).
Cachexia associated with HIV/AIDS hypothesized to be related to an increase in the production
of cytokines ( especially tumor necrosis factor [TNF]) with resultant hypermetabolism (10).
One researcher noted that the majority (68%) of AIDS patients in their study were
hypermetabolic (8). Additionally, some have noticed that when AIDS patients become infected
with opportunistic infections, a decreased food intake often did not lead to a compensatory
decrease in metabolic rate, thus theoretically causing weight loss and wasting (8). Others have
failed to find this paradox, and increased amounts of cytokines were not always found to correlate
with hypermetabolism (8).
While the exact mechanism for the relationship between cytokine production, metabolic
disturbances, viral burden, and weight loss are not completely understood, several hypotheses
exist: endocrine abnormalities and altered macronutrient metabolism (8). Endocrine abnormalities
that are currently under study include: 1) alteration in thyroid hormone triiodothyronine levels
leading to hypermetabolism and 2) decreased levels of testosterone and dehydroepiandrosterone
(DHEA) in men associated with cytokine dysregulation, and loss of nutrients and weight (8).

However, these areas are still controversial, and further studies need to be done in these areas.
Altered macronutrient metabolism appears to be due to cytokine dysregulation. In murine
(adult mice) AIDS, the TNF is found to increase hepatic lipogenesis and hepatic release of very
low density lipoproteins (VLDLs) (8). TNF also seems to inhibit adipocyte lipoprotein lipase and
enhance adipocyte lipolysis (8). Thus, fatty acids are mobilized and shuttled to the liver where
they are packed into VLDLs. The VLDLs are then released into the bloodstream and circulate
throughout the body. However, the VLDLs can not be broken down to release the fat; therefore
the fat is not stored or used for energy but remains circulating the bloodstream in the VLDL form
(8, 11). Other cytokines have been suggested to also interact with lipoproteins and result in a
decrease clearance of triglycerides from the body (11). This inability to use fat as an energy
source especially in the presence of malnutrition results in the body's use of lean tissue mass
(proteolysis) in order to supply the body with needed energy (11). There seems to also be futile
cycling of glucose (8). However, it is not as common as fat cycling.
TNF may also enhance viral replication through a positive feedback mechanism (11).
When HIV is taken into a macrophage, the cell stimulates the production ofTNF. The TNF then
may increase viral replication in that cell as well as other mononuclear phagocytes. Thus, as more
cells are infected with HIV, they in turn increase the amount of TNF produced in the body.

ANTIOXIDANTS ANDS AIDS
In addition to altered macronutrient metabolism, micronutrient deficiencies also play a role
in the development of wasting syndrome and AIDS (10). Micronutrient deficiencies can decrease
immune function (12). Antioxidants (P-carotene, vitamin C, vitamin E, and selenium) seem to be
of particular interest in the latest research.
It has been hypothesized that humans infected with HIV experience chronic oxidative

stress which may play a role in stimulating HIV replication (13). Allard et al. (14) did a study on
lipid peroxidation and plasma antioxidant micronutrient levels in patients with HIV infection.
Forty-nine nonsmoking HIV seropositive subjects without any active opportunistic infections and
15 age-matched seronegative controls were provided with a preliminary diet that consisted of a
polyunsaturated to saturated fat ratio of O.3: 1 for two weeks. Blood samples were then collected
from each participant to be evaluated for plasma carotenes, plasma a and y tocopherol, vitamin C,
selenium, zinc, and lipid peroxides. HIV-positive subjects had significantly lower levels of vitamin
C, a and y tocopherol, P-carotene, and selenium than controls. Additionally, lipid peroxidation
was significantly higher in the HIV-positive group.
Kotler (15) also suggested that reactive oxygen species accentuate viral replication.
Oxidants are believed to further contribute to the development of HIV into AIDS by enhancing
the loss of CD4 cells by apoptosis ( programmed cells death). Antioxidants were hypothesized to
have a role in the treatment of viral diseases from alleviating disease symptoms and decreasing the
long term effects of chronic oxidative stress.
While it appears that HIV-positive patients experience chronic oxidative stress and have
lower plasma levels of antioxidants, the question that remains is whether supplementation with
antioxidants is beneficial. Delmas-Beauvieux et al. (16) studied the effect of selenium and Pcarotene supplementation in HIV-infected patients. Thirty-seven HIV-infected subjects (18
receiving a placebo, 14 receiving oral selenium supplements of 100 µg/day, 13 receiving oral Pcarotene supplements of 60 mg/day) were given treatment of a placebo, selenium supplement, or
P-carotene supplement for 12 months to determine the effect on enzyme activity and selenium
concentrations in the body. At the end of the study, those supplemented with selenium had a
significantly higher selenium concentration and activity of one enzyme (glutathione peroxidase)

compared to baseline levels and other treatments. The placebo group decreased in all areas and
P-carotene supplementation decreased in all areas except for enzyme activity of glutathione
peroxidase. However, the amount of increased activity was not significant.
In another study (17), 72 HIV-positive patients were randomly assigned to two groups.
The first received 60 mg of P-carotene orally 3 times daily, and the other group received a
matched placebo. Additional to the treatment supplement, all participants took a multivitamin.
Baseline values for T-cells subsets, natural killer cells, HIV p24 antigen, serum P-carotene levels,
and a complete blood count were obtained from each participant at the beginning of the study and
were retaken at I month and at 3 months into the study. The results showed no significant
difference in blood values except for serum P-carotene concentrations between treatment
regimens. The researchers hypothesized that the lack of difference could have been due to the
fact that both groups received a multivitamin. However, a similar studies (18) done on Pcarotene supplementation have failed to show any major changes in the total lymphocyte counts
and showed significant increases in T-cells for 3 months of supplementation. However, this effect
diminished after 4 months of treatment, even thought the subjects remained on the P-carotene
supplements.
Further studies on selenium also showed a beneficial effect. Hori et al. (19) evaluated the
effectiveness of selenium supplementation in vitro on HIV replication. Supplementation of
selenium occurred three days before exposure ofT-lymphocyte and monocyte cells to TNF. The
results showed that selenium partially helped to suppress induction of HIV- I replication in both
chronically infected T-cells and monocytes. However, in acute infection of HIV in both types of
cells exposed to TNF, selenium only helped to suppress replication in monocytes and not in Tlymphocytes. Interestingly enough, selenium had no effect on HIV replication in monocytes and

T-lymphocytes when the cells were not exposed to TNF. This suggests that selenium has a
protective effect against TNF-induced HIV replication. Selenium is also beneficial because it
increases activity in cellular antioxidant selenoproteins: glutathione peroxidase, and thioredoxin
reductase.
Wang et al. (20) did a study on female mice infected with a retrovirus functionally similar
to human AIDS to determine the effect of vitamin E supplementation on cytokine production.
Retrovirus infection occurred the day before vitamin E supplementation was begun.
Supplementation occurred at 150 IU/day, 1500 IU/day, and 4500 IU/day for 10 weeks. Results
showed that concentrations of hepatic and serum levels of vitamin E were significantly decreased
by the retrovirus infection. Vitamin E supplementation at all levels significantly increased hepatic
and serum levels. However, supplementation with 1500 IU/day and 4500 IU/day did not further
increase either hepatic or serum levels significantly over 150 IU/day. In cytokine production,
vitamin E supplementation significantly restored production of the cytokines, interleukin-2 (IL-2)
and interferon-y (IFN-y), that are normally suppressed in murine AIDS. While no significant
increase was seen between doses of vitamin in the production of IFN-y, IL-2 production
correlated with the increase in vitamin E supplementation. In interleukin-6 (IL-6), interleukin-I 0,
and TNF levels, vitamin E supplementation significantly reduced secretion which is normally
found to increase in AIDS. For IL-6 and IL-10, supplementation over 150 IU/day showed no
further decrease that was statistically significant. TNF, however, showed further reduction in
1500 IU/day and 4500 IU/day over that of 150 IU/day. Thus, vitamin E supplementation seems
to normalize body vitamin E levels and cytokine production in murine AIDS. This potentially
would help to prevent wasting syndrome which may be related (at least in part) to dysregulation
of cytokine production as was mentioned previously in this paper.
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Another study of vitamin E supplementation, evaluated whether vitamin E helped to
normalize lgE antibody levels in HIV patients. Shor-Posner et al. (21) compared lgE levels in
nine HIV-positive men with vitamin E deficiency with 16 HIV-positive men without vitamin E
deficiency, and 20 HIV-negative men. The results showed a dramatic increase in IgE levels: 308
+/-112 IU/ml, 118 +/- 41 IU/ ml, and 59.5 +/- 15.7 IU/ml, respectively. This study also found a
strong relationship between IgE levels and CDS cell counts. It is hypothesized that vitamin E
induces a decrease in immunosuppressor prostaglandins and other lipid peroxidation products to
normalize IgE levels in the body and improve immune response.
While P-carotene supplementation did not seem to not have much of an effect on immune
function, vitamin E and selenium supplementation appear to have a beneficial effect on the
immune system through antioxidant functions and normalizing cytokine and other body secretion
regulation. No studies were found on the effect of vitamin C supplementation in AIDS. The
mechanism for their beneficial effect may be related to their antioxidant function. By protecting
cells from oxidative damage, they may also reduce production of cytokines and other secretions
that enhance viral replication. This is turn would result lower the amount of cells that would be
infected and destroyed by HIV. Additionally, by altering the body's response to cytokines,
vitamin E and selenium may be helpful in the preventing wasting syndrome which is also known to
decrease immune function.

ALCOHOL AND AIDS
Alcohol is also a hot topic in AIDS research, since heavy alcohol consumption seems to be
a tendency of those individuals infected with HIV. To begin heavy alcohol consumption is
common among intravenous drug users and has been associated with sexual inhibition; thus
placing those people at high risk of being exposed to HIV infection (8,22). Bagasra et al. (22) did

a study on the effect of ethanol on HIV infection. Twelve healthy, seronegative subjects
abstained from alcohol for 10 days prior to the study. Nine were injected with 500 mg/kg of
ethanol, and three were injected with saline. Blood was drawn from each subject at 30 minutes
before injection and 30 minutes, 1 hour, 2 hours, 24 hours, 48 hours, 72 hours, and 120 hours
after injection. Each subjects blood was then infected with HIV in vitro. As assessed by mean
HIV-1 p24 antigen levels, infusion of ethanol was associated with an increase in the replication of
HIV.
Previous studies done by the same group of researchers also showed that alcohol
consumption was associated with a decline in the functions of helper and suppressor T
lymphocytes (22). Other studies have shown that in people who consumed a large amount of
alcohol progression from HIV infection to AIDS took only a few months compared with the 7-11
years that was mentioned before (8). Another study was done involving HIV infected subjects
and uninfected controls who were heavy alcohol drinkers (8). When the HIV infected subjects
quit drinking, they had an increase of 41% in CD4+ cells while uninfected controls only had a
15% increase.
In studies done on murine AIDS, alcohol acted as a cofactor for enhancement of the
progression of AIDS by worsening cytokine disturbances, decreasing immune function, and
further suppressing resistance to pathogens common in AIDS patients (8). HIV infection, as well
as alcohol, both separately caused antioxidant loss from tissues resulting in further damage to
DNA and loss of lymphocyte function (8). This suggests that not only does alcohol have a direct
effect of immune depression, but also an indirect effect of malnutrition through decreased
consumption of other nutrient dense foods and malabsorption. Both effects enhance the
progression of AIDS (8).

CONCLUSIONS
From looking at these studies, it would appear that alcohol consumption has a depressive
effect on the immune system which enhances progression ofIDV to AIDS. Also, a indirect effect
of malnutrition may contribute to wasting syndrome, and therefore enhancing the progression of
AIDS. Supplementation of vitamin E and selenium appears to be helpful in preventing cytokine
dysregulation to decrease viral replication and prevent wasting syndrome. However, the effect of
P-carotene supplementation is not as clear. Clearly, more research is needed in these areas to
substantiate what has been found.

REFERENCES
1. Center of Disease Control. Update: Trends in AIDS incidence in the United States. Morbidity
and Mortality Weekly Report. 1997;46(37): 861-6.
2. Heller LS, Shattuck D. Nutrition support for children with HIV/AIDS. Journal of the
American Dietetic Association. 1997;97(5): 473-4.
3. Watson R. Nutrition and AIDS. Boca Raton, Florida: CRC Press Inc.; 1994.
4. Zeman FJ. Clinical Nutrition and Dietetics. New York, New York: Macmillan Publishing
Company; 1991.
5. Fox CH. The Pathogenesis of HIV Disease. The Journal of Nutrition. 1996;126:2608S-10S.
6. Gottschlich MM, Matarese LE, Shronts EP. Nutrition Support Dietetics. Silver Springs, MD:
ASPEN; 1993.
7. Mahan LK, Escott-Stump S. Krause's Food, Nutrition, and Diet Therapy. Philadelphia,
Pennsylvania: W.B Saunders Company; 1996.
8. Liang B, Lee J, Watson RR. Nutritional Deficiencies in AIDS Patients: A Treatment
Opportunity. Estratto dalla rivista EOS. 1997; 17(1): 12-20.
9. Benenson AS. Control of Communicable Diseases Manual. Washington, DC: American
Public Health Association; 1995.
10. Babameto G, Kotler DP. Malnutrition in HIV infection. Gastroenterology Clinics of North
America. 1997;26(2):393-415.
11. Miller TL. Malnutrition: metabolic changes in children, comparisons with adults. The
Journal of Nutrition. 1996;126:2623S-31S.
12. Beisel WR. Nutrition and Immune Function: Overview. The Journal of Nutrition.
1996;126:2611S-15S.
13. Peterhans E. Oxidants and Antioxidants in Viral Diseases: Disease Mechanisms and
Metabolic Regulation. Journal of Nutrition. 1997;127(5):962S-5S.
14. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant
rnicronutrients in humans with human immunodeficiency syndrome infection. American Journal of
Clinical Nutrition. 1998;67:143-7.
15. Kotler DP. Antioxidant therapy and HIV infection. American Journal of Clinical Nutrition.
1998;67:7-9.

16. Delmas-Beauvieux MC, Peuchant E, Couchouron A, Constans J, Sergeant C, SimonoffM,
Pellegrin JL, Leng B, Conri C, Clerc M. The enzymatic antioxidant system in blood and
glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of
supplementation with selenium or P-carotene. American Journal of Clinical Nutrition.
1996;64: 101-7.
17. Coodley GO, Coodley MK, Lusk R, Green TR, Bakke AC, Wilson D, Wachenheim D,
Sexton G, Salveson C. P-Carotene in HIV infection: an extended evaluation. AIDS.
1996; 10(9):967-73.
18. Garewal HS, Ampel NM, Watson RR, Prabhala RH, Dols CL. A preliminary trial ofbetacarotene in subjects infected with the human immunodeficiency virus. The Journal of Nutrition.
1992; 122(3 Suppl):728-32.
19. Hori K, Hatfield D, Maldarelli F, Lee BJ, Clouse KA. Selenium supplementation suppresses
tumor necrosis factor alpha-induced HIV type 1 replication in vitro. AIDS Research of Human
Retroviruses. 1997; 13(15): 1325-32.
20. Wang Y, Huang DS, Wood S, Watson RR. Modulation of immune function and cytokine
production by various levels of vitamin E supplementation during murine AIDS.
lmmunopharmocology. 1995;29:225-233.
21. Shor-Posner G, Mugyez-Burbano MJ, Lu Y, Feaster D, Fletcher M, Sauberlich H, Baum
MK. Elevated IgE level in relationship to nutritional status and immune parameters in early HIV-I
disease. The Journal of Allergy and Clinical Immunology. 1995;95(4):886-892.
22. Bagasra 0, Bachman SE, Jew L, Tawadros R, Cater J, Boden G, Ryan I, Pomerantz RJ.
Increased human immunodeficiency virus type 1 replication in human peripheral blood
mononuclear cells induced by ethanol: potential immunopathogenic mechanisms. The Journal of
Infectious Diseases. 1996; 173:550-8.

